RECRUITING

Evaluating the Impact of Limited Compared with Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients with Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This phase II trial studies how anxiety is affected by 2 types of follow-up after surgery, limited follow-up and intense follow-up, in patients with stage II-III soft tissue sarcoma of the trunk and extremities. In cancer survivors, the fear of cancer coming back (recurring) is common and may persist long after the end of treatment. It may also be exacerbated by return visits for imaging (surveillance). The purpose of this study is to determine how patients' anxiety and other cancer-related outcomes are affected by how often surveillance is done.

Official Title

Evaluating the Impact of Limited Vs. Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients with Soft Tissue Sarcoma

Quick Facts

Study Start:2020-12-28
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04751409

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * ≥18 years old
  2. * Completion of sarcoma therapy (chemotherapy, radiation therapy and/or surgery) within 8-14 weeks of study enrollment
  3. * Willingness to complete surveys x 2 years
  1. * Documented metastatic disease at the time of enrollment
  2. * Non-English-speaking patients

Contacts and Locations

Study Contact

Christina L Roland, MD
CONTACT
713-792-6940
clroland@mdanderson.org

Principal Investigator

Christina L Roland, MD
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Christina L Roland, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-12-28
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2020-12-28
Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC V8
  • Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC V8
  • Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC V8
  • Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC V8